Martha Read, MD
Family Medicine · Decatur, ALNPI 1427465434
Payments from drug & device makers
Across 114 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$446
- AbbVie$265
- Amarin Pharma, Inc.$222
- Amgen$111
- AstraZeneca$96
- Daiichi Sankyo Inc.$57
- plus $595 from 19 others
What the payments were for
- Food & beverage$1,791100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $446 |
| AbbVie | 21 | $265 |
| Amarin Pharma, Inc. | 14 | $222 |
| Amgen | 6 | $111 |
| AstraZeneca | 6 | $96 |
| Daiichi Sankyo Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Indivior Inc. | 2 | $53 |
| Astellas Pharma US Inc | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| GSK | 3 | $46 |
| Corcept Therapeutics | 2 | $42 |
| Merck | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Exact Sciences | 2 | $36 |
| Seqirus USA Inc | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Mylan Specialty L.p. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Harmony Biosciences LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$1,791 in reported general payments places this provider in the 65th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 59 | $401 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $339 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $182 |
| Gabapentin | 11 | $162 |
| Atorvastatin Calcium | 18 | $140 |
| Levothyroxine Sodium | 16 | $135 |
| Losartan Potassium | 16 | $115 |
| Lisinopril | 17 | $111 |
| Metoprolol Succinate | 11 | $110 |
| Tizanidine Hcl | 14 | $102 |
| Doxycycline Hyclate | 14 | $100 |
| Amlodipine Besylate | 15 | $98 |
| Amoxicillin | 18 | $84 |
| Meloxicam | 14 | $53 |
| Levofloxacin | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Decatur
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
- Timothy HowardHuntsville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.